1,3-Diphenyl-1H-pyrazole-4-carbaldehyde, 99.0%, 2.5g

4-BROMO-5,6,7,8-TETRAHYDROISOQUINOLINE, 95.0%, 250mg

2-Methyl-6-(methylsulfanyl)aniline, 95%, 5g

2,5-Dioxopyrrolidin-1-yl 4-hydroxybenzoate, 97%, 100mg

methyl 2-phenylimidazo[1,2-a]pyridine-7-carboxylate, 97%, 500mg

[1,1'-Bi(cyclohexane)]-2,2'-diol (mixture of isomers)>98.0%(GC)5g

2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-OL, 95.0%, 250mg

(3S,4R,5R)-3,4,5,6-TETRAHYDROXY-1-MORPHOLINOHEXAN-2-ONE, 97%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 0.10 µm, 1 Piece(s)

4-Amino-5-iodo-2-(trifluoromethyl)benzonitrile, 97.0%, 10g

2,4,6-Trifluorobenzenesulfonamide, 5g

ethyl 1-ethyl-3-nitro-1H-pyrazole-5-carboxylate, 250mg

1-Undecyne, 96.0%, 25g